Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00137943 · ClinicalTrials.gov registry record · Phase 1
Parents Matter!: Interventions to Promote Effective Parent-Child Communication
A Phase 1 study of HIV Infections and Pregnancy, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 1
- Development phase
- 2,210
- Enrollment target
- 3
- Study locations
NCT00137943 is a Phase 1 study of HIV Infections and Pregnancy that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 2,210 participants, above the 442-participant average among 542 other HIV Infections trials with a reported enrollment target (400% higher). The trial reports 3 study locations across 2 states.
The verdict
NCT00137943, a Phase 1 study of HIV Infections and Pregnancy, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 2,210 participants
- Enrollment target
- 3
- Study locations
Study Summary
Parents Matter is a community-based project whose goal it is to develop and test an intervention designed to promote effective parent-child communication about sexuality in order to promote sexual health among adolescents.
Conditions Studied
Interventions
- BEHAVIORAL Full Parent communication intervention
- BEHAVIORAL Brief Parent Communication Intervention
- BEHAVIORAL Control Parent Intervention
Study Locations (3)
Georgia
- University of Georgia - Athens
- Georgia State University - Atlanta
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,210 participants |
| Start Date | 1999-09 |
| Est. Completion | 2006-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00137943
The ClinicalTrials.gov registry entry for NCT00137943 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 2,210 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 442-participant average among 542 other HIV Infections trials with a reported enrollment target (400% higher). The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 3 interventions - of which Full Parent communication intervention is the first listed.
NCT00137943 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Georgia, Arkansas.
Frequently Asked Questions
What is clinical trial NCT00137943 about?
NCT00137943 is a clinical study titled "Parents Matter!: Interventions to Promote Effective Parent-Child Communication". Parents Matter is a community-based project whose goal it is to develop and test an intervention designed to promote effective parent-child communication about sexuality in order to promote sexual health among adolescents.
What is the current status of trial NCT00137943?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 2,210 participants. The study started on 1999-09. Estimated completion is 2006-09.
What conditions does trial NCT00137943 study?
This clinical trial studies the following conditions: HIV Infections, Pregnancy, Sexually Transmitted Diseases.
What interventions are being tested in trial NCT00137943?
The interventions under investigation include: Full Parent communication intervention (BEHAVIORAL), Brief Parent Communication Intervention (BEHAVIORAL), Control Parent Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00137943?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00137943 being conducted?
This trial has 3 study locations across Arkansas, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
RECRUITING · Phase 1
-
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
RECRUITING · Phase 1
-
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
RECRUITING · Phase 1
-
First Time in Human Study of Long Acting VH4524184 Formulations
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.